ID
16920
Description
Lapatinib for Brain Metastases In ErbB2-Positive Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00263588
Link
https://clinicaltrials.gov/show/NCT00263588
Keywords
Versions (1)
- 8/14/16 8/14/16 -
Uploaded on
August 14, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Neoplasms, Breast NCT00263588
Eligibility Neoplasms, Breast NCT00263588
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
pregnant or lactating
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0032961
- UMLS CUI [1,2]
- C0006147
Description
conditions that would effect the absorption of an oral drug
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0678745
- UMLS CUI [1,2]
- C0001563
Description
Hypersensitivity to gadolinium contrast agents
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0020517
- UMLS CUI [1,2]
- C3249258
Description
Cerebrovascular disease
Data type
boolean
Alias
- UMLS CUI [1]
- C0007820
Description
Medical or psychiatric disorder that would interfere with patient safety or informed consent
Data type
boolean
Alias
- UMLS CUI [1,1]
- C1321605
- UMLS CUI [1,2]
- C0439801
- UMLS CUI [1,3]
- C0009488
- UMLS CUI [2,1]
- C0021430
- UMLS CUI [2,2]
- C0439801
- UMLS CUI [2,3]
- C0009488
Similar models
Eligibility Neoplasms, Breast NCT00263588
- StudyEvent: Eligibility
C0220650 (UMLS CUI [1,2])
C0085203 (UMLS CUI [2,1])
C0220650 (UMLS CUI [2,2])
C0232741 (UMLS CUI [2])
C0006147 (UMLS CUI [1,2])
C0001563 (UMLS CUI [1,2])
C3249258 (UMLS CUI [1,2])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
C0021430 (UMLS CUI [2,1])
C0439801 (UMLS CUI [2,2])
C0009488 (UMLS CUI [2,3])